Drug intelligence / Profile preview

PITO-002

Development stage: Unknown
Lead developer: Aquavit Pharmaceuticals
Administration: Topical

Overview

PITO-002 is a proprietary compounding platform technology developed by Aquavit Pharmaceuticals. It is specifically designed to facilitate the creation of personalized topical formulations, extending the company's AQT series of treatments. The platform focuses on optimizing the delivery and stability of compounded medications for dermatological and aesthetic applications. It is intended to be used as a foundational technology for developing customized skin treatments that can be applied topically, potentially in conjunction with micro-channeling or other advanced delivery systems.

Beyond the preview

Go deeper on PITO-002.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PITO-002.

Explore the full profile